Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol-Reference-Cited by-同舟云学术

Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol

Published:2017-06 Issue:6 Volume:7 Page:e015081
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Arndtz Katherine,Corrigan Margaret,Rowe Anna,Kirkham Amanda,Barton Darren,Fox Richard P,Llewellyn Laura,Athwal Amrita,Wilkhu Manpreet,Chen Yung-Yi,Weston Chris,Desai Amisha,Adams David H,Hirschfield Gideon M

Funder

Efficacy and Mechanism Evaluation Programme

Publisher

BMJ

Subject

General Medicine

Reference14 articles.

1. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden;Lindkvist;Hepatology,2010

2. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community;Bambha;Gastroenterology,2003

3. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis;Molodecky;Hepatology,2011

4. Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden;Bergquist;Scand J Gastroenterol,2007

5. Interactions between chronic liver disease and inflammatory bowel disease;Loftus;Inflamm Bowel Dis,1997

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The first selective VAP-1 inhibitor in China, TT-01025-CL: safety, tolerability, pharmacokinetics, and pharmacodynamics of single- and multiple-ascending doses;Frontiers in Pharmacology;2024-04-29

2. Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: Open-label, multicenter, single-arm, phase II trial;Hepatology Communications;2024-04-26

3. Noninvasive prognostic models, imaging, and elastography to predict clinical events in primary sclerosing cholangitis: A review;World Journal of Hepatology;2023-09-27

4. Current Therapeutics in Primary Sclerosing Cholangitis;Journal of Clinical and Translational Hepatology;2023-04-17

5. An overview of recent treatment options for primary sclerosing cholangitis;Annals of Gastroenterology;2023